MedPath

The effect of remimazolam on postoperative memory retention and delayed regeneration in breast surgery patients: Rationale and design of an exploratory, randomized, open, propofol-controlled, single-center clinical trial.

Not Applicable
Conditions
Breast cancer
Registration Number
JPRN-UMIN000045593
Lead Sponsor
Kyushu University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
74
Inclusion Criteria

Not provided

Exclusion Criteria

Patients should be excluded if any one of the following criteria apply. (1) Patients with a history of hypersensitivity to remimazolam or propofol. (2) Patients with egg or soybean oil allergies, acute angle-closure glaucoma, myasthenia gravis, serious disease complications, or a history of allergies. (3) Patients with an ASA (American society of anesthesiologists) physical status of IV or higher, shock, or coma. (4) Patients who are judged as inappropriate for inclusion in the study. (5) Patients with impaired cognitive function.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath